Photrexa (Avedro, Inc.)
Welcome to the PulseAid listing for the Photrexa drug offered from Avedro, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Avedro, Inc. |
| NON-PROPRIETARY NAME: | riboflavin 5-phosphate ophthalmic |
| SUBSTANCE NAME: | RIBOFLAVIN 5'-PHOSPHATE SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | SOLUTION/ DROPS |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-04-15 |
| END MARKETING DATE: | 0000-00-00 |
Photrexa HUMAN PRESCRIPTION DRUG Details:
| Item Description | Photrexa from Avedro, Inc. |
| LABELER NAME: | Avedro, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1.46(mg/mL) |
| START MARKETING DATE: | 2016-04-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 25357-023_776655eb-0d0d-48c8-beb8-0e7b69af1e88 |
| PRODUCT NDC: | 25357-023 |
| APPLICATION NUMBER: | NDA203324 |
Other RIBOFLAVIN 5'-PHOSPHATE SODIUM Pharmaceutical Manufacturers / Labelers:
| Manufacturer / Labeler | Proprietary Name |
